This company seems to have been delisted
Reason: Acquired by Johnson & Johnson
Last recorded trade on: August 1, 2024
Source: https://www.jnj.com/media-center/press-releases/johnson-johnson-completes-acquisition-of-abiomed
Reason: Acquired by Johnson & Johnson
Last recorded trade on: August 1, 2024
Source: https://www.jnj.com/media-center/press-releases/johnson-johnson-completes-acquisition-of-abiomed
Abiomed
ABMD
$606.00
Share price
0.00%
Change (1 day)
N/A
Change (1 year)
Categories
Abiomed is an American medical devices company that develops and manufactures the circulatory support device Impella, the world’s smallest heart pump.
Abiomed (ABMD) Fails to deliver data
Key failure to deliver metrics for Abiomed:
- Last SEC data release: 2023-10-31
- Last 15 days FTD volume: N/A
- Last 3 months FTD volume: N/A
- Last year FTD volume: N/A
A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.
Failures to deliver for Abiomed (ABMD) - 3 months history
Number of shares, 3 months chart
Biweekly Failures to deliver volume for Abiomed (ABMD) - since 2013
Volume in USD (price x number of shares), data since 2013Abiomed (ABMD) Failure to deliver volume, Year over Year
| Year | Volume (Price x Shares) | Change |
|---|---|---|
| 2022 | A$33.77 M | -38.73% |
| 2021 | A$55.12 M | 177.91% |
| 2020 | A$19.83 M | -81.11% |
| 2019 | A$0.10 B | 9.91% |
| 2018 | A$95.55 M | 270.12% |
| 2017 | A$25.81 M | -23.06% |
| 2016 | A$33.55 M | 58.42% |
| 2015 | A$21.17 M | -26.41% |
| 2014 | A$28.78 M | 1249.72% |
| 2013 | A$2.13 M |
FTD volume in the last 3 months for similar companies or competitors
| Company | FTD volume (3 months) | FTD volume (1 year) | Country |
|---|---|---|---|
 | A$13.21 M | A$32.59 M | 🇺🇸 USA |
 | A$4.76 M | A$73.37 M | 🇺🇸 USA |
 | A$1.33 M | A$3.39 M | 🇺🇸 USA |